Filing identity and reporting period
Important mismatch: The supplied filing is for General Aircraft, Inc., a development-stage helicopter rental company—not Xenetic Biosciences, Inc. It reports the quarter and six months ended February 29, 2012. The company was incorporated on August 9, 2011, so there is no comparable prior-year operating period presented.
Financial performance and position
- Revenue: $35,967 for the three months and $49,716 for the six months ended February 29, 2012, from renting a Robinson R44 helicopter for tours and pilot training.
- Expenses and losses: Three-month operating expenses were $62,034 and net loss was $29,264. Six-month operating expenses were $90,601 and net loss was $47,433. Six-month operating loss was $40,885; interest expense was $6,548. The filing reports inception-to-date net loss of $55,668.
- Margins: Six-month operating and net margins were approximately negative 82% and negative 95%, respectively. The company had not established profitable operations.
- Cash flow: Six-month operating cash flow was positive $1,355, while investing and financing cash flows were zero during that six-month period. The operating cash flow benefited from increases in accounts payable and accrued expenses; cash ended at $11,355. No cash interest or taxes were reported as paid.
- Liquidity: Current assets were $47,394, including $36,039 of accounts receivable; current liabilities were $83,894. Working capital was negative $36,500.
- Debt: Long-term secured aircraft debt was $212,813 at 6% interest, with interest-only payments due semiannually and principal due August 11, 2016. The helicopter’s net book value was $203,645.
Material changes and capital
- Compared with August 31, 2011, cash increased from $10,000 to $11,355, accounts receivable rose from zero to $36,039, and current liabilities increased from $7,922 to $83,894. The company moved from $1,765 of equity to a $45,668 stockholders’ deficit.
- After February 29, the company completed an offering of 3.5 million shares at $0.01 per share for $35,000. The filing reports 13.5 million shares outstanding as of April 23, 2012.
- The CEO, CFO, and director roles changed in October 2011. The aircraft is managed by Elite Aviation VGT, LLC, a related party, under a month-to-month agreement.
Outlook, risks, and contingencies
- Management estimated approximately 500 rental hours annually and an average long-term rate of $370 per hour, but stated there was no assurance those estimates would be achieved. The reported average rental rate through the period was approximately $341 per hour.
- Management estimated operating costs of $336.90 per rental hour at the assumed rate and utilization, leaving estimated gross profit of about $33.10 per hour. These estimates are sensitive to utilization, fuel, maintenance, and other costs.
- The company expects a helicopter overhaul at 2,200 lifetime operating hours, estimated to cost approximately $170,000. Management anticipated needing additional financing for part of that cost and noted financing may not be available on feasible terms.
- The financial statements disclose substantial doubt about the company’s ability to continue as a going concern. Continued operations depend on financing and/or generating sufficient revenue and ultimately achieving profitability. Management said it did not expect to seek further financing during the remainder of the fiscal year, following the $35,000 offering.
- Disclosure controls were described as ineffective due to staffing and resource limitations, including inadequate segregation of duties and reconciliation procedures. A later controls discussion in the filing says controls were effective at a reasonable-assurance level, creating an internal inconsistency.
- The filing reports no pending legal proceedings and no off-balance-sheet arrangements.
Important facts for investors to verify
- Confirm the issuer: this document identifies General Aircraft, Inc., not Xenetic Biosciences, Inc.
- Reconcile the six-month operating-expense figure: the financial statements report $90,601, while MD&A reports $90,061.
- Review the disclosure-controls conclusion given the conflicting statements about effectiveness.
- Assess collection of the $36,039 receivable and the composition and payment timing of the $76,798 in accounts payable and accrued expenses.
- Evaluate going-concern funding needs, the helicopter overhaul estimate, and dependence on the related-party manager and a single aircraft.